Control of PI(3) kinase in Tregcells maintains homeostasis and lineage stability

Nature Immunology

Volumn 16, Issue 2, 2015, Pages 188-196

  Huynh, Alexandria ^a,b   Dupage, Michel ^c   Priyadharshini, Bhavana ^b   Sage, Peter T ^a   Quiros, Jason ^c   Borges, Christopher M ^a,b   Townamchai, Natavudh ^d   Gerriets, Valerie A ^e   Rathmell, Jeffrey C ^e   Sharpe, Arlene H ^a   Bluestone, Jeffrey A ^c   Turka, Laurence A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHULALONGKORN UNIVERSITY   (Thailand)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL LINEAGE; CONTROLLED STUDY; ENZYME ACTIVITY; HOMEOSTASIS; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH1 CELL; ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FLOW CYTOMETRY; GENE DELETION; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; CELL LINEAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE DELETION; HOMEOSTASIS; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84922917657     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3077     Document Type: Article

References (50)

1. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003
2. Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336 (2003
3. Huynh, A., Zhang, R. & Turka, L.A. Signals and pathways controlling regulatory T cells. Immunol. Rev. 258, 117-131 (2014
4. Webster, K.E., et al. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-Term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206, 751-760 (2009
5. Burchill, M.A., Yang, J., Vogtenhuber, C., Blazar, B.R. & Farrar, M.A. IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178, 280-290 (2007
6. Ward, S.G., Ley, S.C., MacPhee, C. & Cantrell, D.A. Regulation of D-3 phosphoinositides during T cell activation via the T cell antigen receptor/CD3 complex and CD2 antigens. Eur. J. Immunol. 22, 45-49 (1992
7. Di Cristofano, A., et al. Impaired Fas response and autoimmunity in Pten+/- mice. Science 285, 2122-2125 (1999
8. Stambolic, V., et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39 (1998
9. Suzuki, A., et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14, 523-534 (2001
10. Liu, X., et al. Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice. J. Clin. Invest. 120, 2497-2507 (2010
11. Bensinger, S.J., et al. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J. Immunol. 172, 5287-5296 (2004
12. Zeiser, R., et al. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 111, 453-462 (2008
13. Zanin-Zhorov, A., et al. Scaffold protein Disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function. Proc. Natl. Acad. Sci. USA 109, 1625-1630 (2012
14. Sauer, S., et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 105, 7797-7802 (2008
15. Zeng, H., et al. mTORC1 couples immune signals and metabolic programming to establish Treg-cell function. Nature 499, 485-490 (2013
16. Haxhinasto, S., Mathis, D. & Benoist, C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565-574 (2008
17. Ouyang, W., et al. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11, 618-627 (2010
18. Ouyang, W., et al. Novel Foxo1-dependent transcriptional programs control Treg cell function. Nature 491, 554-559 (2012
19. Walsh, P.T., et al. PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs. J. Clin. Invest. 116, 2521-2531 (2006
20. Koch, M.A., et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602 (2009
21. Li, J., et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947 (1997
22. Xiong, H., et al. Characterization of two distinct lymphoproliferative diseases caused by ectopic expression of the Notch ligand DLL4 on T cells. PLoS ONE 8, e84841 (2013
23. Zhang, R., et al. An obligate cell-intrinsic function for CD28 in Tregs. J. Clin. Invest. 123, 580-593 (2013
24. Backman, S.A., et al. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet. 29, 396-403 (2001
25. McGeachy, M.J., Stephens, L.A. & Anderton, S.M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175, 3025-3032 (2005
26. Hill, J.A., et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27, 786-800 (2007
27. Wang, R. & Green, D.R. Metabolic checkpoints in activated T cells. Nat. Immunol. 13, 907-915 (2012
28. Frauwirth, K.A., et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769-777 (2002
29. Michalek, R.D., et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299-3303 (2011
30. Polansky, J.K., et al. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38, 1654-1663 (2008
31. Miyao, T., et al. Plasticity of Foxp3+ T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36, 262-275 (2012
32. Komatsu, N., et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20, 62-68 (2014
33. Wan, Y.Y. & Flavell, R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766-770 (2007
34. Rubtsov, Y.P., et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667-1671 (2010
35. Shrestha, S., et al. The PTEN-mTORC2 axis coordinates Treg cell stability and control of TH1 and TFH cell flexibility. Nat. Immunol. doi:10.1038/ni.3076 (5 January 2015
36. Smigiel, K.S., et al. CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J. Exp. Med. 211, 121-136 (2014
37. Zhou, X., et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007 (2009
38. Bailey-Bucktrout, S.L., et al. Self-Antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 39, 949-962 (2013
39. Hsieh, C.S., Zheng, Y., Liang, Y., Fontenot, J.D. & Rudensky, A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7, 401-410 (2006
40. Delgoffe, G.M., et al. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature 501, 252-256 (2013
41. Garcia-Cao, I., et al. Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell 149, 49-62 (2012
42. Gwinn, D.M., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226 (2008
43. Delgoffe, G.M., et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30, 832-844 (2009
44. Dang, E.V., et al. Control of TH17/Treg balance by hypoxia-inducible factor 1. Cell 146, 772-784 (2011
45. Patterson, S.J., et al. Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. J. Immunol. 186, 5533-5537 (2011
46. Ali, K., et al. Inactivation of PI(3)K p110d breaks regulatory T-cell-mediated immune tolerance to cancer. Nature 510, 407-411 (2014
47. Zhou, X., et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205, 1983-1991 (2008
48. Rubtsov, Y.P., et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558 (2008
49. Badea, T.C., Wang, Y. & Nathans, J. A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse. J. Neurosci. 23, 2314-2322 (2003
50. Vander Heiden, M.G., et al. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 21, 5899-5912 (2001